Previous retrospective studies have suggested that 5-alpha-reductase inhibitors may beneficial effects on bladder cancer development and/or recurrence, but a prospective cohort study found no protective effect.
A study of patients undergoing radical prostatectomy found that those chronic kidney disease or end-stage renal disease have a higher risk of 30- and 90-day readmission and 1-year mortality.
In a retrospective study, addition of carboplatin to chemotherapy regimens improved survival in men with metastatic castration-resistant prostate cancer whose disease progressed on second-generation hormone therapy.
Combination radiation treatment and radical prostatectectomy Gleason 9 to 10 prostate cancer are associated with similar cancer-specific mortality, a study found.
Testosterone levels among adolescents and young men in the United States declined significantly from 1999 to 2016, and data suggest the trend is related to increases in body mass index, a study found.
Cytoreductive radical prostatectomy following neoadjuvant androgen-deprivation therapy (ADT) in men with hormone-naïve low-volume metastatic prostate cancer improves survival long-term vs ADT alone, a study found.
In a study, patients with high-risk nonmuscle invasive bladder cancer receiving bacillus Calmette-Guérin intravesical therapy rather than upfront cystectomy had improved cancer-specific survival by 10 percentage points.
Patients with upper tract urothelial carcinoma (UTUC) benefit from surgery with bladder cuff resection. Otherwise, their prognosis hinges on mostly unmodifiable factors, according to investigators presenting new study findings during the American Urological Association 2020 Virtual Experience. Michael Staehler, MD, PhD, of Ludwig Maximilian University of Munich, and colleagues identified 231 UTUC patients (median age…
Each 1 mL/min/1.73 m2 decline in estimated glomerular filtration rate was associated with a 3.7% increased risk of stone development in the following 2 years in adjusted analyses, a study found.
